Breaking News

Goodwin Biotechnology Expands Capacity

Invests in doubling space available for cGMP capacity as it readies for further expansion of its biopharma manufacturing business

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Goodwin Biotechnology has recently purchased the two-acre site where the company has operated for over 26 years in order to expand its capacity to meet the needs of its long-term clients. The company is a U.S.-based, FDA-registered, uniquely qualified and flexible full GMP biopharmaceutical contract development and manufacturing organization (CDMO) that offers a fully integrated Single Source Solution from cell line development, process development including bioconjugation, scale-up, cGMP contra...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters